Since both PCSK9 outcome trials demonstrated impressive safety when LDL-C levels are lowered into ranges much lower than 70 mg/dL, what should be the approach of the interventional and medical cardiologist to achieving LDL-C levels in this range?

Since both PCSK9 outcome trials demonstrated impressive safety when LDL-C levels are lowered into ranges much lower than 70 mg/dL, what should be the approach of the interventional and medical cardiologist to achieving LDL-C levels in this range?

Since both PCSK9 outcome trials demonstrated impressive safety when LDL-C levels are lowered into ranges much lower than 70 mg/dL, what should be the approach of the interventional and medical cardiologist to achieving LDL-C levels in this range?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

J. Wouter Jukema, MD, PhD, FESC, FACC MC

J. Wouter Jukema, MD, PhD, FESC, FACC MC

Professor of Cardiology
Netherlands Heart Foundation
Chairman, Leiden Vascular Medicine
Leiden University Medical Center (LUMC)
Leiden, Netherlands